⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
accessnewswire.com
EYPT
REGN
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Regeneron Pharmaceuticals, Inc. to Contact the Firm Today!
accessnewswire.com
REGN
September 14, 2026 Deadline Approaching: Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN) – Contact Levi & Korsinsky
accessnewswire.com
REGN
Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Class Action Lawsuit Reminder from Pomerantz LLP for Investors of Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
accessnewswire.com
EYPT
REGN
Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Investors - Lead Plaintiff Deadline on September 14, 2026
accessnewswire.com
REGN
Pomerantz LLP Reminds Shareholders with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit – REGN
accessnewswire.com
REGN
Securities Lawsuit Alert: Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN